Neuroendocrine tumors (NETs) form a group of rare but clinically relevant tumors that originate from neuroendocrine cells. These cells exhibit features of both neurons and hormone-releasing endocrine cells, and they can break off and spread to various parts of the body. Therefore, neuroendocrine tumors can develop in a variety of organs, mainly in the gastrointestinal tract, pancreas, and lungs.
Neuroendocrine tumors differ from many cancers due to the following features:
Their temperamental behavior makes early awareness and management critical, helping patients and families feel more in control of their health.
Not all neuroendocrine tumors are aggressive; some are low-grade and slow-growing, while others are high-grade and aggressive. Nonetheless, all NETs are considered potentially malignant and require careful evaluation and long-term follow-up.
Neuroendocrine tumors can occur in the following parts:
Other organs, such as the thymus or adrenal glands, would be less common.
This distinction clearly affects the presentation and detection of the tumors.
The challenges of early detection of NETs stem from their difficult-to-describe symptoms; however, acknowledging this will lead to watchful waiting and, when symptoms persist or recur, further evaluation.
Over time, many neuroendocrine tumors develop unnoticed and may present vague or nonspecific symptoms. Nonfunctional NETs, especially, may remain unseen for years and are eventually discovered by chance during imaging or surgery for other medical issues.
The precise cause of most neuroendocrine tumors is not known; they develop following genetic changes in neuroendocrine cells that eventually grow in an uncontrolled manner.
Certain factors may increase risk, including:
However, most patients with NETs present without identifiable risk factors.
Most NETs occur sporadically. A smaller number associated with inherited genetic conditions may require family screening and genetic counseling.
Symptoms vary widely depending on tumor location and hormone production. Typical symptoms include:
Functional NETs may cause hormonal symptoms, including:
Symptoms can vary in intensity over time, complicating diagnosis.
These cells showed properties typical of both nerve and endocrine cells, which secrete hormones and distribute them throughout the body.
Regular blood tests help assess:
Tumor grading is the stage diagnosis of such tumors. It describes how quickly tumor cells replicate, with consequences directly tied to treatment choice and prognosis.
Grading shows the tumoral division speed. In low-grade tumors, growth is slow; in high-grade tumors, growth is aggressive. Tumor grade is essential for treatment planning.
In many cases, a biopsy helps to confirm the diagnosis and determine the grade. In others, the absence of a biopsy would depend on imaging findings or clinical context to suggest treatment.
Staging malignancies entails assessing their size, whether they have involved regional lymph nodes, and whether they have distant metastases. Staging, therefore, offers valuable prognostic information and helps one determine treatment options.
NETs can spread to the:
The liver is the most common site of metastases, specifically in gastrointestinal NETs.
The treatment depends upon:
Usually, it needs a multi-disciplinary approach involving surgery and medical therapy when indicated.
Surgery or operation is the primary treatment for localized neuroendocrine tumors; it can become necessary in well-selected cases of metastatic disease.
Surgery aimed at tumor debulking and symptom control may be possible in selected patients with metastatic disease.
Surgical procedures may include:
The goal is complete tumor removal whenever possible.
Yes. Laparoscopic or minimally invasive access techniques may apply to many neuroendocrine tumors located in the gastrointestinal tract, depending on the patient's size and location.
Benefits include:
These benefits are essential, especially for someone requiring complex or staged treatments.
Yes, medical treatments include the following:
These are used to control not only the growth of the tumor but also the hormonal symptoms that they cause.
Hormonal production is reduced by medicines that improve the patient's quality of life and well-being while stabilizing the disease.
Almost all such cases need long-term follow-up and treatment to give the patient a sense of reassurance about continued support, especially for slow-growing or metastatic tumors.
Neuroendocrine tumors recur or progress slowly over time. Thereby, regular follow-up helps:
Following up usually involves:
Very diverse. Some patients live relatively symptom-free lives, while others may require ongoing medical support. Education and symptom control go hand in hand in preserving quality of life.
In most cases, patients can continue working and performing their daily activities with symptom management and supportive therapy.
Yes. Living with conditions like chronic or cancerous ones can be emotionally taxing. Psychological support and counseling can enhance coping and well-being.
Prognosis depends on the following factors:
Most localized low-grade tumors have an excellent prognosis.
In most cases, the early stages of operable cases are curable. In advanced cases, treatment can control the disease for prolonged periods.
Tender Palm Super-Speciality Hospital offers advanced Neuroendocrine Tumors treatment in Lucknow, India, at an affordable cost. We have a team of experienced oncologists and surgeons who provide accurate diagnoses with advanced imaging and personalized surgical treatment. Our General and Laparoscopic Surgery team has decades of experience in successfully treating Neuroendocrine Tumors in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com